Works matching IS 02724391 AND DT 2023 AND VI 84 AND IP 2

Results: 16

A novel copper chelator for the suppression of colorectal cancer.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 312, doi. 10.1002/ddr.22034

By:

Shi, Xiaolong;
Li, Ying;
Jia, Mengting;
Zhang, Zhixin;
Huang, Lunhua;
Zhang, Miaomiao;
Xun, Qingqing;
Jiang, Di;
Liu, Yanrong

Publication type:

Article

Discovery of 4‐(4‐aminophenyl)‐6‐phenylisoxazolo[3,4‐b]pyridine‐3‐amine derivatives as novel FLT3 covalent inhibitors for the intervention of acute myeloid leukemia.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 296, doi. 10.1002/ddr.22032

By:

Wang, Qing‐Xin;
Wang, Yi‐Bo;
Sha, Jiu‐Kai;
Zhou, Hai;
Liu, Jia‐Chuan;
Wu, Jia‐Zhen;
Tong, Zhen‐Jiang;
Cai, Jiao;
Chen, Zi‐Jun;
Zhang, Chen‐Qian;
Zheng, Xin‐Rui;
Wang, Jing‐Jing;
Wang, Xiao‐Long;
Xue, Xin;
Yu, Yan‐Cheng;
Ding, Ning;
Leng, Xue‐Jiao;
Dai, Wei‐Chen;
Sun, Shan‐Liang;
Chang, Liang

Publication type:

Article

Novel acetic acid derivatives containing quinazolin‐4(3H)‐one ring: Synthesis, in vitro, and in silico evaluation of potent aldose reductase inhibitors.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 275, doi. 10.1002/ddr.22031

By:

Tokalı, Feyzi Sinan;
Demir, Yeliz;
Türkeş, Cüneyt;
Dinçer, Büşra;
Beydemir, Şükrü

Publication type:

Article

Two new alkaloids from Dendrobium nobile Lindl. exhibited neuroprotective activity, and dendrobine alleviated Aβ<sub>1−42</sub>‐induced apoptosis by inhibiting CDK5 activation in PC12 cells.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 262, doi. 10.1002/ddr.22030

By:

Zhang, Cheng‐Chen;
Kong, Yan‐Li;
Zhang, Mao‐Sheng;
Wu, Qin;
Shi, Jing‐Shan

Publication type:

Article

Pramipexole inhibits formalin‐induce acute and long‐lasting mechanical hypersensitivity via NF‐kB pathway in rats.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 253, doi. 10.1002/ddr.22029

By:

Santamaria‐Anzures, Jazmín;
Pérez‐Ramos, Julia;
Mendoza‐Pérez, Felipe;
Godínez‐Chaparro, Beatriz

Publication type:

Article

Thrombospondin‐1 mimic peptide PKHB1 induced endoplasmic reticulum stress‐mediated but CD47‐independent apoptosis in non‐small cell lung cancer.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 238, doi. 10.1002/ddr.22028

By:

Ye, Jiani;
Yao, Yinan;
Zhao, Jianfeng;
Cui, Luyun;
Lu, Guohua;
Wang, Qing;
Zhang, Pei;
Zhou, Jianying

Publication type:

Article

PDE4 inhibitor Roflumilast modulates inflammation and lipid accumulation in PCOS mice to improve ovarian function and reduce DHEA‐induced granulosa cell apoptosis in vitro.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 226, doi. 10.1002/ddr.22027

By:

Ji, Xiaowei;
Ye, Yao;
Wang, Lin;
Liu, Suying;
Dong, Xi

Publication type:

Article

Progress of small molecules for targeted protein degradation: PROTACs and other technologies.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 337, doi. 10.1002/ddr.22026

By:

Zhao, Hong‐Yi;
Xin, Minhang;
Zhang, San‐Qi

Publication type:

Article

Treatment strategies and pharmacist‐led medication management for Helicobacter pylori infection.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 326, doi. 10.1002/ddr.22025

By:

Wang, Yu‐Zhen;
Chen, Jie;
Pei, Shi‐Qin;
Wang, Chen;
Han, Gang;
Kan, Lian‐Di;
Li, Liu‐Cheng

Publication type:

Article

Oridonin ameliorates acetaminophen‐induced acute liver injury through ATF4/PGC‐1α pathway.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 211, doi. 10.1002/ddr.22024

By:

Yu, Dongsheng;
Li, Jiye;
Wang, Yu;
Guo, Danfeng;
Zhang, Xiaodan;
Chen, Mingming;
Zhou, Zheng

Publication type:

Article

Novel EGFR‐MAPK kinase and ABC transporter inhibitors for HepG2 resistant to Erlotinib.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 200, doi. 10.1002/ddr.22023

By:

Ostlund, Trevor;
SutraDhar, Kakan;
Elgazwi, Sara M.;
Mahnashi, Mater;
Kyeremateng, Jennifer;
Iram, Surtaj;
Halaweish, Fathi

Publication type:

Article

A new series of thiazole‐hydrazone hybrids for Akt‐targeted therapy of non‐small cell lung cancer.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 185, doi. 10.1002/ddr.22022

By:

Orujova, Turana;
Ece, Abdulilah;
Akalın Çiftçi, Gülşen;
Özdemir, Ahmet;
Altıntop, Mehlika D.

Publication type:

Article

Urolithin A suppresses tumor progression and induces autophagy in gastric cancer via the PI3K/Akt/mTOR pathway.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 172, doi. 10.1002/ddr.22021

By:

Zhang, Yingjing;
Jiang, Lin;
Su, Pengfei;
Yu, Tian;
Ma, Zhiqiang;
Liu, Yuqin;
Yu, Jianchun

Publication type:

Article

Therapeutic role of Artemether in the prevention of hepatic steatosis through miR‐34a‐5p/PPARα pathway.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 156, doi. 10.1002/ddr.22020

By:

Chen, Li;
Yu, Shuang;
Hong, Shubing;
Lin, Xia;
Zhu, Xiaonan;
Cao, Xiaopei;
Li, Yanbing;
Xiao, Haipeng

Publication type:

Article

Anlotinib improves bile duct ligature‐induced liver fibrosis in rats via antiangiogenesis regulated by VEGFR2/mTOR pathway.

Published in:

Drug Development Research, 2023, v. 84, n. 2, p. 143, doi. 10.1002/ddr.22019

By:

Lei, Jun;
Li, Qing;
Xu, Hongyan;
Luo, Ming;
Liu, Zhiwen;
Xiang, Deng;
Chen, Peiqun

Publication type:

Article

Issue Information.

Published in:: Drug Development Research, 2023, v. 84, n. 2, p. 141, doi. 10.1002/ddr.21944
Publication type:: Article